Michael Baldwin - Concepedia

Author

Michael Baldwin

Boehringer Ingelheim (Germany)ORCID

Also Known As

Baldwin M, M Baldwin, M. Baldwin, M. L. Baldwin, M.L. Baldwin, Michael Baldwin, Michael L. Baldwin

Publications

953

Citations

H-Index

Concepts

All Affiliations

Boehringer Ingelheim (Germany)National Jewish Health University of Colorado Denver Novartis (United Kingdom)NHO Kinki Chuo Chest Medical Center

About

Michael Baldwin is an author at Boehringer Ingelheim (Germany) specializing in medicine, public health, and clinical epidemiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	201
2	Business	1	1	21
3	Education	1	1	18
4	Health Sciences	1	1	64
5	Law	1	1	21

Michael Baldwin

Publications

814

Citations

H-Index

Page 1

	Year	Citations
The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK David Price, Guy Brusselle, Kevin Gruffydd‐Jones, International Journal of COPD	2015	152
Interpersonal Influence as Active Coping: Effects of Task Difficulty on Cardiovascular Reactivity Timothy W. Smith, Michael Baldwin, Alan J. Christensen Psychophysiology Active CopingBehavioral Decision MakingSocial PsychologySocial InfluenceCommunication	1990	94
Clinical high-risk designation does not predict excess fetal-maternal hemorrhage Paul M. Ness, Michael Baldwin, Jennifer R. Niebyl American Journal of Obstetrics and Gynecology Postpartum HemorrhageClinical High-risk DesignationClinical EpidemiologyPatient SafetyGynecology	1987	67
Alloimmunization to D antigen and HLA in D‐negative immunosuppressed oncology patients Michael Baldwin, Paul M. Ness, D'Maris E. Scott, Transfusion HistocompatibilityImmunohematologyImmunologyD-positive Red CellsPathology	1988	64
Comparative efficacy of long-acting bronchodilators for COPD - a network meta-analysis Shannon Cope, James F. Donohue, Jeroen P. Jansen, Respiratory Research	2013	62
Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis Marlies Wijsenbeek, Jeffrey J. Swigris, Yoshikazu Inoue, European Respiratory Journal	2023	46
Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world study Kevin Gruffydd‐Jones, Guy Brusselle, Rupert Jones, npj Primary Care Respiratory Medicine AsthmaFamily MedicinePulmonary CareAdvanced Lung DiseasePediatric Lung Disease	2016	39
The Living with Pulmonary Fibrosis questionnaire in progressive fibrosing interstitial lung disease Jeffrey J. Swigris, Katelyn Cutts, Natalia Male, ERJ Open Research	2021	37
Detection and quantitation of fetal maternal hemorrhage utilizing an enzyme‐linked antiglobulin test Jeffrey Riley, Paul M. Ness, S. J. Taddie, Transfusion	1982	30
Improving Clinical Reality in Chronic Obstructive Pulmonary Disease Economic Modelling Yumi Asukai, Michael Baldwin, Tiago A. H. Fonseca, PharmacoEconomics	2013	24

Page 1